ArticleScientific reports2017

A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients.

Qi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.